Our recent work demonstrated that the EDA2R signalling mediates tumour‐induced Atrogin1 and MuRF1 expression in muscle tissue, placing EDA2R at upstream of these atrophy markers.5 The gene discussed is FBXO32; the disease is neoplasm.